Wrist-Worn RFID Antenna Printed on Additive Manufactured Flexible Substrate

We assess the feasibility of fabricating a flexible RFID wrist-worn antenna printed on a substrate manufactured using 3D-printing technology, as to enable full customization of the bracelet at low cost. Numerical results show adequate power transmission to the RFID chip. Also, the fabricated prototype shows enough flexibility to be bent around the wrist.info:eu-repo/semantics/acceptedVersio

Development of a Transmission-Based Open-Ended Coaxial-Probe Suitable for Axillary Lymph Node Dielectric Measurements

We assess the feasibility of a transmission-based open-ended coaxial-probe for tissue dielectric properties estimation. The ultimate goal is to use it for axillary lymph node dielectric measurement, which is not trivial when applying the state-of-the-art reflection-based open-ended coaxial-probe. The proposed technique consists in placing the material under test between two opposite open-ended coaxial-probes and record the transmission coefficient. We numerically assess three coaxial probe configurations, in order to ensure adequate transmission and sensing volume. The final setup allows for enough propagation through a 5mm sample (which will be sufficient for the measurements of axillary lymph nodes), while confining the sensing volume to the region of interest. Experimental tests on two materials of different permittivity ranges showed good agreement between the measured and numerical transmission coefficient. Moreover, we observed that the transmission coefficient can highlight the contrast between materials with different dielectric properties. The promising initial results motivate the further application of the method to the case of axillary lymph nodes.info:eu-repo/semantics/acceptedVersio

Development of MRI‐based axillary numerical models and estimation of axillary lymph node dielectric properties for microwave imaging

Purpose: Microwave imaging (MWI) has been studied as a complementary imaging modality to improve sensitivity and specificity of diagnosis of axillary lymph nodes (ALNs), which can be metastasized by breast cancer. The feasibility of such a system is based on the dielectric contrast between healthy and metastasized ALNs. However, reliable information such as anatomically realistic numerical models and matching dielectric properties of the axillary region and ALNs, which are crucial to develop MWI systems, are still limited in the literature. The purpose of this work is to develop a methodology to infer dielectric properties of structures from magnetic resonance imaging (MRI), in particular, ALNs. We further use this methodology, which is tailored for structures farther away from MR coils, to create MRI- based numerical models of the axillary region and share them with the scientific community, through an open- access repository. Methods: We use a dataset of breast MRI scans of 40 patients, 15 of them with metastasized ALNs. We apply image processing techniques to minimize the artifacts in MR images and segment the tissues of interest. The background, lung cavity, and skin are segmented using thresholding techniques and the remaining tissues are segmented using a K- means clustering algorithm. The ALNs are segmented combining the clustering results of two MRI sequences. The performance of this methodology was evaluated using qualitative criteria. We then apply a piecewise linear interpolation between voxel signal intensities and known dielectric properties, which allow us to create dielectric property maps within an MRI and consequently infer ALN properties. Finally, we compare healthy and metastasized ALN dielectric properties within and between patients, and we create an open- access repository of numerical axillary region numerical models which can be used for electromagnetic simulations. Results: The proposed methodology allowed creating anatomically realistic models of the axillary region, segmenting 80 ALNs and analyzing the corresponding dielectric properties. The estimated relative permittivity of those ALNs ranged from 16.6 to 49.3 at 5 GHz. We observe there is a high variability of dielectric properties of ALNs, which can be mainly related to the ALN size and, consequently, its composition. We verified an average dielectric contrast of 29% between healthy and metastasized ALNs. Our repository comprises 10 numerical models of the axillary region, from five patients, with variable number of metastasized ALNs and body mass index. Conclusions: The observed contrast between healthy and metastasized ALNs is a good indicator for the feasibility of a MWI system aiming to diagnose ALNs. This paper presents new contributions regarding anatomical modeling and dielectric properties' characterization, in particular for axillary region applications.info:eu-repo/semantics/publishedVersio

Development of an Anthropomorphic Phantom of the Axillary Region for Microwave Imaging Assessment

We produced an anatomically and dielectrically realistic phantom of the axillary region to enable the experimental assessment of Axillary Lymph Node (ALN) imaging using microwave imaging technology. We segmented a thoracic Computed Tomography (CT) scan and created a computer-aided designed file containing the anatomical configuration of the axillary region. The phantom comprises five 3D-printed parts representing the main tissues of interest of the axillary region for the purpose of microwave imaging: fat, muscle, bone, ALNs, and lung. The phantom allows the experimental assessment of multiple anatomical configurations, by including ALNs of different size, shape, and number in several locations. Except for the bone mimicking organ, which is made of solid conductive polymer, we 3D-printed cavities to represent the fat, muscle, ALN, and lung and filled them with appropriate tissue-mimicking liquids. Existing studies about complex permittivity of ALNs have reported limitations. To address these, we measured the complex permittivity of both human and animal lymph nodes using the standard open-ended coaxial-probe technique, over the 0.5 GHz-8.5 GHz frequency band, thus extending current knowledge on dielectric properties of ALNs. Lastly, we numerically evaluated the effect of the polymer which constitutes the cavities of the phantom and compared it to the realistic axillary region. The results showed a maximum difference of 7 dB at 4 GHz in the electric field magnitude coupled to the tissues and a maximum of 10 dB difference in the ALN response. Our results showed that the phantom is a good representation of the axillary region and a viable tool for pre-clinical assessment of microwave imaging technology.info:eu-repo/semantics/publishedVersio

Nocturnal blood pressure fall as predictor of diabetic nephropathy in hypertensive patients with type 2 diabetes

<p>Abstract</p> <p>Background</p> <p>Hypertensive patients with reduced blood pressure fall (BPF) at night are at higher risk of cardiovascular events (CVE).</p> <p>Methods</p> <p>We evaluated in hypertensive diabetic patients, if a reduced nocturnal BPF can precedes the development of diabetic nephropathy (DN). We followed 70 patients with normal urinary albumin excretion (UAE) for two years. We performed 24-hours ambulatory BP monitoring in baseline and at the end of the study.</p> <p>Results</p> <p>Fourteen (20%) patients (GI) developed DN (N = 11) and/or CVE (n = 4). Compared to the remaining 56 patients (GII) in baseline, GI had similar diurnal systolic (SBP) and diastolic BP (DBP), but higher nocturnal SBP (138 ± 15 vs 129 ± 16 mmHg; p < 0.05) and DBP (83 ± 12 vs 75 ± 11 mmHg; p < 0,05). Basal nocturnal SBP correlated with occurrence of DN and CVE (R = 0.26; P < 0.05) and with UAE at the end of the study (r = 0.3; p < 0.05). Basal BPF (%) correlated with final UAE (r = -0.31; p < 0.05). In patients who developed DN, reductions occurred in nocturnal systolic BPF (12 ± 5 vs 3 ± 6%, p < 0,01) and diastolic BPF (15 ± 8 vs 4 ± 10%, p < 0,01) while no changes were observed in diurnal SBP (153 ± 17 vs 156 ± 16 mmHg, NS) and DBP (91 ± 9 vs 90 ± 7 mmHg, NS). Patients with final UAE < 20 μg/min, had no changes in nocturnal and diurnal BP.</p> <p>Conclusions</p> <p>Our results suggests that elevations in nocturnal BP precedes DN and increases the risk to develop CVE in hypertensive patients with T2DM.</p

Gestão por competências em organizações de governo

Ao longo dos últimos anos vem se ampliando os espaços e o interesse, no meio acadêmico e empresarial, pelas discussões sobre uso da abordagem da competência como marco importante para as atividades de gestão de recursos humanos. A difusão dessa abordagem entre as organizações públicas brasileiras é, entretanto, bem mais recente, e conta, ainda hoje, com um número insuficiente de estudos e publicações. É esta a razão da importância e pertinência da publicação do livro " Gestão por competências em organizações de governo"Número de páginas: 100 p.Gestão de PessoasISBN 85-256-0046-

Sealability of MTA and calcium hydroxidecontaining sealers

OBJECTIVES: The aim of this study was to evaluate the apical sealability of Fillapex(®), Endo-CPM-Sealer(®) and Sealapex(®). MATERIAL AND METHODS: Ninety-four freshly extracted single-rooted teeth were selected and decoronated. All teeth were radiographed to confirm the existence of a single and straight root canal, which was prepared using Protaper Universal and 2.5% sodium hypochlorite. The teeth were randomly divided in groups of 10 specimens each according to the sealer, and the canals were filled using the single cone technique and one of the sealers. Four additional teeth were used as controls. The teeth were submitted to dye leakage with Rhodamine B for 24 h but using vacuum on the initial 15 min. Thereafter, they were cut longitudinally and the leakage was measured in a linear fashion from apex to crown. Data were analyzed by ANOVA and Tukey's tests at 5% significance level. RESULTS: Fillapex(®) and Sealapex(®) showed significantly less dye leakage than Endo-CPM-Sealer(®) (p<0.05). CONCLUSIONS: It was concluded that Fillapex(®) and Sealapex(®) were able to prevent apical dye leakage differently from Endo-CPM-Sealer(®)

Canagliflozin and renal outcomes in type 2 diabetes and nephropathy

BACKGROUND Type 2 diabetes mellitus is the leading cause of kidney failure worldwide, but few effective long-term treatments are available. In cardiovascular trials of inhibitors of sodium–glucose cotransporter 2 (SGLT2), exploratory results have suggested that such drugs may improve renal outcomes in patients with type 2 diabetes. METHODS In this double-blind, randomized trial, we assigned patients with type 2 diabetes and albuminuric chronic kidney disease to receive canagliflozin, an oral SGLT2 inhibitor, at a dose of 100 mg daily or placebo. All the patients had an estimated glomerular filtration rate (GFR) of 30 to &lt;90 ml per minute per 1.73 m2 of body-surface area and albuminuria (ratio of albumin [mg] to creatinine [g], &gt;300 to 5000) and were treated with renin–angiotensin system blockade. The primary outcome was a composite of end-stage kidney disease (dialysis, transplantation, or a sustained estimated GFR of &lt;15 ml per minute per 1.73 m2), a doubling of the serum creatinine level, or death from renal or cardiovascular causes. Prespecified secondary outcomes were tested hierarchically. RESULTS The trial was stopped early after a planned interim analysis on the recommendation of the data and safety monitoring committee. At that time, 4401 patients had undergone randomization, with a median follow-up of 2.62 years. The relative risk of the primary outcome was 30% lower in the canagliflozin group than in the placebo group, with event rates of 43.2 and 61.2 per 1000 patient-years, respectively (hazard ratio, 0.70; 95% confidence interval [CI], 0.59 to 0.82; P=0.00001). The relative risk of the renal-specific composite of end-stage kidney disease, a doubling of the creatinine level, or death from renal causes was lower by 34% (hazard ratio, 0.66; 95% CI, 0.53 to 0.81; P&lt;0.001), and the relative risk of end-stage kidney disease was lower by 32% (hazard ratio, 0.68; 95% CI, 0.54 to 0.86; P=0.002). The canagliflozin group also had a lower risk of cardiovascular death, myocardial infarction, or stroke (hazard ratio, 0.80; 95% CI, 0.67 to 0.95; P=0.01) and hospitalization for heart failure (hazard ratio, 0.61; 95% CI, 0.47 to 0.80; P&lt;0.001). There were no significant differences in rates of amputation or fracture. CONCLUSIONS In patients with type 2 diabetes and kidney disease, the risk of kidney failure and cardiovascular events was lower in the canagliflozin group than in the placebo group at a median follow-up of 2.62 years